← Leaderboards
Aimee Merino
University Of Minnesota
$744,113
Attributed
$744,113
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $149.1K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$744,113 · 1
By mechanism
K08$744,113 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Branden S Moriarity$9,306,595
- Frank Cichocki$2,728,802
- Jakub Tolar$8,610,650
- Bruce R. Blazar$144,460,093
Others in their field
Other Emerging Leaders on “Acute Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Leonard Freedman · Leidos Biomedical Research, Inc.$12,430,568
- Crystal Mackall · Children'S Hosp Of Philadelphia$12,361,966
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,557,384
- Karen R Rabin · Baylor College Of Medicine$5,475,660
- Christopher A Miller · Washington University$5,424,298
Research focus
Acute LeukemiaCellular BiologyAdoptive TransferAcute Myelocytic LeukemiaCell TherapyAntigensAntitumor ResponseAutologous TransplantationAdvisory CommitteesBlood CellsAdaptive BehaviorsAllogenicBone MarrowBone Marrow TransplantationCancer CellCancer CenterCancer TherapyCareerCell DensityCell KillingCell PhysiologyCellsBlood SpecimenCheckpoint Receptors
Grant awards (5)
Understanding and improving responses to adaptive NK cell therapy for leukemia and multiple myeloma$149,059
K08 · FY2025 · CA · contact PI
Understanding and improving responses to adaptive NK cell therapy for leukemia and multiple myeloma$149,059
K08 · FY2024 · CA · contact PI
Understanding and improving responses to adaptive NK cell therapy for leukemia and multiple myeloma$148,665
K08 · FY2023 · CA · contact PI
Understanding and improving responses to adaptive NK cell therapy for leukemia and multiple myeloma$148,665
K08 · FY2022 · CA · contact PI
Understanding and improving responses to adaptive NK cell therapy for leukemia and multiple myeloma$148,665
K08 · FY2021 · CA · contact PI